MALIGNANT PLEURAL EFFUSION side effect
What is MALIGNANT PLEURAL EFFUSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
MALIGNANT PLEURAL EFFUSION and Recently Reported Side Effects
MALIGNANT PLEURAL EFFUSION and 15 most Active Side Effect polls
MALIGNANT PLEURAL EFFUSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with MALIGNANT PLEURAL EFFUSION
ARIMIDEX CAMPTOSAR ERLOTINIB FORTEO GEMZAR METASTRON MIFEPRISTONE NEULASTA PEMETREXED SORAFENIB SUNITINIB SUTENT TEMODAL XELODASunitinib Side Effects Report #5481478-1
Consumer or non-health professional from UNITED STATES reported SUNITINIB problem on Oct 05, 2007. Female patient, weighting 209.4 lb, was diagnosed with renal cancer metastatic and was treated with SUNITINIB. After drug was administered, patient experienced the following problems/side effects: malignant pleural effusion, . SUNITINIB dosage: 50 MG DAILY X 28 DAYS PO. During the same period patient was treated with METHADONE, LEXAPRO, ATIVAN, REGLAN, ZOFRAN, AMBIEN, MILK OF MAGNESIA, COLACE. Patient was hospitalized. Patient recovered.
Sorafenib Side Effects Report #5787755-9
SORAFENIB problem was reported by a Physician from UNITED STATES on June 17, 2008. Male patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: malignant pleural effusion, . SORAFENIB dosage: unknown. Patient was hospitalized. Patient recovered.
Xeloda Side Effects Report #5751972-4
Consumer or non-health professional from UNITED STATES reported XELODA problem on May 23, 2008. Female patient, weighting 112.0 lb, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: malignant pleural effusion, . XELODA dosage: unknown. Patient recovered.
Metastron Side Effects Report #5753003-9
METASTRON problem was reported by a Consumer or non-health professional from JAPAN on May 16, 2008. Male patient, 36 years of age, was treated with METASTRON. After drug was administered, patient experienced the following problems/side effects: malignant pleural effusion, . METASTRON dosage: unknown. Patient died on 05/10/2008.
Forteo Side Effects Report #5255968-0
Consumer or non-health professional from FRANCE reported FORTEO problem on Feb 21, 2007. Female patient, 71 years of age, was diagnosed with osteoporosis, respiratory failure, pain and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: malignant pleural effusion, respiratory disorder, . FORTEO dosage: unknown. During the same period patient was treated with OXYGEN, SKENAN. Patient recovered.
Arimidex Side Effects Report #5653040-9
ARIMIDEX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Female patient, 66 years of age, weighting 164.9 lb, was diagnosed with breast cancer and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, malignant pleural effusion, . ARIMIDEX dosage: unknown. During the same period patient was treated with METFORMIN, FLUOXETINE, LIPITOR, OMEPRAZOLE, TRICOR, ASPIRIN. Patient recovered.
Erlotinib Side Effects Report #5624289-6
Physician from UNITED STATES reported ERLOTINIB problem on Feb 08, 2008. Female patient, weighting 111.3 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant pleural effusion, . ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Mifepristone Side Effects Report #5535763-5
MIFEPRISTONE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2007. Female patient, weighting 114.6 lb, was treated with MIFEPRISTONE. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, malignant pleural effusion, pleural fibrosis, . MIFEPRISTONE dosage: 4400 MG. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5551624-X
Consumer or non-health professional from GERMANY reported SUTENT problem on Nov 30, 2007. Male patient, weighting 235.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, malignant pleural effusion, metastases to central nervous system, . SUTENT dosage: DAILY DOSE:50MG. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ALLOPURINOL, LORZAAR, ASPIRIN. Patient was hospitalized. Patient died on 10/19/2007.
Pemetrexed Side Effects Report #5450185-3
PEMETREXED problem was reported by a Physician from JAPAN on Sept 03, 2007. Male patient, 54 years of age, weighting 126.3 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant pleural effusion, post procedural haemorrhage, pulmonary necrosis, . PEMETREXED dosage: 785 MG, OTHER. During the same period patient was treated with CISPLATIN, PANVITAN, METHYCOBAL, DECADRON, KYTRIL, ADONA, TRANSAMIN. Patient was hospitalized. Patient died on 08/01/2007.
Sunitinib Side Effects Report #5763970-5
Health Professional from UNITED STATES reported SUNITINIB problem on June 06, 2008. Male patient, weighting 158.7 lb, was diagnosed with renal cancer metastatic and was treated with SUNITINIB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, malignant pleural effusion, . SUNITINIB dosage: 50 MG QD PO. During the same period patient was treated with OXYCONTIN, OXYCODONE, NORVASC, ATACAND, LIPITOR. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5743384-4
ERLOTINIB problem was reported by a Physician from UNITED STATES on May 15, 2008. Female patient, weighting 127.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease recurrence, malignant pleural effusion, tachycardia, . ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Camptosar Side Effects Report #5327216-4
Consumer or non-health professional from UNITED STATES reported CAMPTOSAR problem on May 14, 2007. Male patient, weighting 47.18 lb, was treated with CAMPTOSAR. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant pleural effusion, respiratory distress, . CAMPTOSAR dosage: 64 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/04/2005.
Camptosar Side Effects Report #5333452-3
CAMPTOSAR problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2007. Male patient, weighting 47.18 lb, was treated with CAMPTOSAR. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant pleural effusion, refusal of treatment by relative, respiratory distress, . CAMPTOSAR dosage: 64 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 01/04/2005.
Gemzar Side Effects Report #5553966-0
Physician from UNITED STATES reported GEMZAR problem on Dec 01, 2007. Female patient was diagnosed with ovarian cancer recurrent, hypothyroidism and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: fatigue, malignant neoplasm progression, malignant pleural effusion, pericardial effusion, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, SYNTHROID, ACIPHEX, PROCRIT, NEUPOGEN, EMEND, ZOFRAN, COMPAZINE. Patient recovered.
Temodal Side Effects Report #5582865-3
TEMODAL problem was reported by a Physician from JAPAN on Dec 25, 2007. Male patient, 64 years of age, weighting 90.39 lb, was diagnosed with ependymoma malignant and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, lung neoplasm malignant, malignant pleural effusion, nausea, pneumonia aspiration, pneumonia staphylococcal, . TEMODAL dosage: 150 MG/M2;QD;PO, 200 MG/M2;QD;PO, 200 MG/M2;QD;PO, 200 MG/M2;QD;PO. During the same period patient was treated with PHENYTOIN CAP, CYANOCOBALAMIN, RINDERON. Patient died on 03/05/2007.
Neulasta Side Effects Report #5425990-X
Physician from UNITED STATES reported NEULASTA problem on Aug 15, 2007. Female patient, weighting 169.1 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: anaemia, leukocytosis, malignant pleural effusion, pneumonia, ventricular tachycardia, . NEULASTA dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, CARAFATE, PROTONIX, LEVOTHYROXINE, POTASSIUM CHLORIDE, ALBUTEROL, ATROVENT. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5376920-0
GEMZAR problem was reported by a Physician from JAPAN on June 25, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea, . GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Gemzar Side Effects Report #5388359-2
Physician from JAPAN reported GEMZAR problem on July 06, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea, . GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Gemzar Side Effects Report #5376920-0
GEMZAR problem was reported by a Physician from JAPAN on June 25, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea, . GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Gemzar Side Effects Report #5388359-2
Physician from JAPAN reported GEMZAR problem on July 06, 2007. Male patient, 62 years of age, weighting 121.9 lb, was diagnosed with bile duct cancer, ascites and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, malignant pleural effusion, nausea, . GEMZAR dosage: 1600 MG, OTHER. During the same period patient was treated with LASIX. Patient was hospitalized. Patient died on 02/25/2007.
Erlotinib Side Effects Report #5765626-1
ERLOTINIB problem was reported by a Physician from UNITED STATES on June 06, 2008. Female patient, weighting 127.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease recurrence, dyspnoea, malignant pleural effusion, tachycardia, . ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Arimidex Side Effects Report #5730841-X
Physician from UNITED STATES reported ARIMIDEX problem on Apr 30, 2008. Female patient, 66 years of age, weighting 164.9 lb, was diagnosed with breast cancer and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, malignant pleural effusion, . ARIMIDEX dosage: unknown. During the same period patient was treated with METFORMIN, FLUOXETINE, LIPITOR, OMEPRAZOLE, TRICOR, ASPIRIN. Patient recovered.
Sutent Side Effects Report #5694984-1
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 25, 2008. Female patient, 49 years of age, weighting 158.7 lb, was diagnosed with breast cancer and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hypoxia, malignant pleural effusion, neuralgia, oedema, . SUTENT dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Gemzar Side Effects Report #5369423-0
Physician from JAPAN reported GEMZAR problem on June 19, 2007. Male patient, 78 years of age, was diagnosed with prophylaxis, hypertension, constipation, pain, abdominal pain upper, insomnia and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphangiosis carcinomatosa, malignant pleural effusion, pericardial effusion, scan with contrast abnormal, . GEMZAR dosage: 800 MG/M2, UNK. During the same period patient was treated with RINDERON, ADALAT, DILTIAZEM, MAGLAX, LOXONIN, SELBEX, DEPAS, NASEA. Patient was hospitalized. Patient recovered.
Neulasta Side Effects Report #5341126-8
NEULASTA problem was reported by a Physician from UNITED STATES on May 21, 2007. Female patient, weighting 169.1 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: anaemia, leukocytosis, malignant pleural effusion, pneumonia, ventricular tachycardia, . NEULASTA dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, CARAFATE, PROTONIX, LEVOTHYROXINE, POTASSIUM CHLORIDE, ALBUTEROL, ATROVENT. Patient was hospitalized. Patient recovered.